Photoselective vaporization of the prostate uses green-wavelength laser energy that is strongly absorbed by hemoglobin. The surgeon vaporizes tissue while coagulating blood vessels, creating a urinary channel without producing resection chips.
The procedure is often discussed when bleeding risk is important, but it is still an operating-room prostate surgery—not an office treatment—and anticoagulant management must remain individualized.
Where PVP is strongest
PVP is widely used in small and moderate-size glands and can treat selected larger prostates in experienced hands. It can address lateral tissue and a middle lobe. Operative time and durability become more operator- and size-dependent as gland volume increases.
Its hemostatic profile can be attractive for patients with cardiovascular comorbidity or antithrombotic complexity. “Lower bleeding risk” does not mean “continue every blood thinner without a plan.” The treating surgeon and prescribing clinician must coordinate.
The pathology tradeoff
Because tissue is vaporized, there is usually no meaningful specimen for pathologic examination. PSA, examination, imaging, and cancer-risk evaluation should therefore be appropriately addressed before surgery.
This does not mean every patient needs a biopsy before PVP. It means the absence of tissue should be an intentional decision rather than an overlooked consequence.
Recovery, ejaculation, and durability
Catheter duration is often brief, and bleeding may be less than after TURP. Burning, urgency, frequency, intermittent blood, temporary retention, and fatigue still occur. Irritative symptoms can be prominent when a large surface area is vaporized.
Dry or retrograde ejaculation is common with standard PVP. Erectile function is usually preserved. Randomized evidence supports good symptom relief, while some registry and long-term analyses show more reoperation than TURP or enucleation.
Capability questions
- Which laser platform and power does the surgeon use?
- How many PVP cases has the surgeon performed at my gland size?
- What is the plan for my antiplatelet or anticoagulant therapy?
- Has prostate-cancer risk been addressed given the lack of a tissue specimen?
- Why PVP rather than HoLEP, TURP, or Aquablation at this center?
Bottom line
GreenLight PVP is an established tissue-vaporizing operation with an important hemostatic advantage, balanced against common ejaculatory change, no pathology specimen, and size-dependent durability.
Sources and evidence
Open the original guideline, regulatory record, or study. Evidence was last checked August 14, 2026.
-
AUA Guideline (2026) Part III: Procedural/Surgical Management The Journal of Urology · professional guideline · 2026
-
Disease Management — Management of Non-neurogenic Male LUTS European Association of Urology · professional guideline · 2026